We are live on ! Find out more
HRMY icon

Harmony Biosciences

44 hedge funds and large institutions have $926M invested in Harmony Biosciences in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.83% more ownership

Funds ownership: 0%44.83% (+45%)

Holders
44
Holders Change
+44
Holders Change %
% of All Funds
0.89%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
44
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

HRMY Hedge Fund Activity: Q3 2020 in Review

44 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q3 2020, worth a combined $926M.

Buyers outnumbered sellers: 44 funds opened new HRMY positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $330M.

  • 44 institutional investors held Harmony Biosciences (HRMY) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $926M of Harmony Biosciences stock for Q3 2020.
  • 44 funds opened new Harmony Biosciences positions in Q3 2020 and 0 closed out, a net change of +44 holders.
  • The largest Harmony Biosciences buyer in Q3 2020 was Fidelity Investments, an estimated $330M added.

Based on aggregated 13F filings for Q3 2020.